Tuberculosis is a global burden with oneĂ˘Â€Â“third of the worldĂ˘Â™s population infected with the pathogen Mycobacterium tuberculosis complex and an annual 1.4 million deaths from the disease. This high incidence of infection and the increased rate of multi-drug resistant and extensively-drug resistant strains of the organism further complicated the problem of TB control and have called for an urgent need to develop new anti-TB drugs from plants. OMICS Group International is an open access publisher and scientific event organizer. OMICS Group publishes 700+ peer-reviewed journals with the support of about 25000 editorial board members.
Last date updated on March, 2021